WOC

The WOC Skin Health Weekly®, a weekly e-news publication packed with career empowerment resources including the latest clinical, industry, and product news, clinical education, market research, and of course, the most recently posted jobs requiring expertise in the prevention and treatment of skin breakdown and wound care. Over 20,000 clinicians now receive the WOC Skin Health Weekly.

Read the most recent issue of the WOC Skin Health Weekly®

Receive your own complimentary subscription to the WOC Skin Health Weekly®

Sign Up Now!


Featured Articles

July 30, 2019

Nasal Decolonization: Potential Mupirocin Alternatives for SSI Prevention

Staphylococcus aureus nasal carriage is a proven risk factor for the development of staphylococcal surgical site infections, or SSIs. S. aureus infections are associated with increased length of hospital stays, increased mortality and higher costs of medical care. Nasal colonization rates with S. aureus have been reported to reach up to 30%, with 1% to 3% having methicillin-resistant organisms.Nasal decolonization strategies have proven beneficial in reducing not only S. aureus colonization but also S. aureus SSIs.  Read More  

Bioinspired Wound Dressing Contracts in Response to Body Heat to Speed Healing

Cuts, scrapes, blisters, burns, splinters, and punctures—there are a number of ways our skin can be broken. Most treatments for skin wounds involve simply placing a barrier over it (usually an adhesive gauze bandage) to keep it moist, limit pain, and reduce exposure to infectious microbes, but do not actively assist in the healing process. More sophisticated wound dressings that can monitor aspects of healing such as pH and temperature and deliver therapies to a wound site have been developed in recent years, but they are complex to manufacture, expensive, and difficult to customize, limiting their potential for widespread use. Read More

Discordant Themes Exist in Skin Cancer Assessment Outcomes Among Physicians, Patients

Areas of disagreement between patients and physicians on skin cancer-related outcomes include patient fear of the unknown, recurrence and empowering patients to make treatment choices, according to researchers in Dermatologic Surgery. “The shift from a physician/disease-specific point of view to a patient-oriented one has created a new set of qualitative outcomes,” Anthony M. Rossi, MD, of the dermatology service at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College in New York, and colleagues wrote. Read More

Rare Skin Lymphoma Appears Treatable with Antibiotics

It is common for patients with a rare lymphoma, cutaneous T-cell lymphoma (CTCL), to also contract staphylococcal infections in the skin. CTCL is a cancer of the T-cells in the skin. CTCL can also involve the blood, lymph nodes, and other internal organs. Researchers with the LEO Foundation Skin Immunology Research Center at the Faculty of Health and Medical Sciences, the University of Copenhagen, showed that aggressive antibiotic treatment could not only inhibit the staph infection, but also the cancer cells. Read More